announcements & circulars-凯发88

english 凯发88-凯发vip-娱乐凯发app下载中文繁体

english 凯发88-凯发vip-娱乐凯发app下载中文繁体

investors

information disclosure

listing documents

financial reports

announcements & circulars

company presentation

corporate governance

stock information

ir contacts

email subscription

announcements & circulars

the announcement begins in december 2019

continuing connected transaction announcement - renewal of the master technical service agreement 2022-01-14
monthly return of equity issuer on movements in securities for the month ended 31 december 2021 2022-01-06
connected transaction announcement - renewal of the lease agreement 2022-01-03
next day disclosure return 2021-12-06
monthly return of equity issuer on movements in securities for the month ended 30 november 2021 2021-12-03
next day disclosure return 2021-11-26
grant of award shares under the restricted share award scheme 2021-11-25
voluntary announcement - kn035 (envafolimab) obtained marketing approval in china from nmpa 2021-11-25
voluntary announcement - ind approval by nmpa for a phase iii clinical trial of kn046 for the treatment of advanced pdac 2021-11-23
monthly return of equity issuer on movements in securities for the month ended 31 october 2021 2021-11-04